All lobbying filings
Ardelyx, Inc.
Ardelyx, Inc. filed a Q4 report for Ardelyx, Inc. on January 19, 2026.
Lobbying for Ardelyx, Inc.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 19, 2026
Expenses
$580,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
4
Lobbying activity
1
Access to innovative kidney treatments, ESRD PPS, coverage of oral only medications for people with ESRD, innovation, Drug pricing, Medicare access to pharmaceuticals